These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28353661)

  • 1. The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients.
    Piciucchi M; Stigliano S; Archibugi L; Zerboni G; Signoretti M; Barucca V; Valente R; Fave GD; Capurso G
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28353661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin.
    Formica V; Morelli C; Ferroni P; Nardecchia A; Tesauro M; Pellicori S; Cereda V; Russo A; Riondino S; Guadagni F; Roselli M
    Cancer Biomark; 2016 Sep; 17(3):335-345. PubMed ID: 27434293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
    Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
    Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Preoperative Nutritional and Immunological Factors in Patients with Pancreatic Ductal Adenocarcinoma.
    Abe T; Nakata K; Kibe S; Mori Y; Miyasaka Y; Ohuchida K; Ohtsuka T; Oda Y; Nakamura M
    Ann Surg Oncol; 2018 Dec; 25(13):3996-4003. PubMed ID: 30225838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC).
    Tao L; Zhang L; Peng Y; Tao M; Li G; Xiu D; Yuan C; Ma C; Jiang B
    Oncotarget; 2016 Nov; 7(45):74314-74324. PubMed ID: 27494847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer.
    Sierzega M; Lenart M; Rutkowska M; Surman M; Mytar B; Matyja A; Siedlar M; Kulig J
    Ann Surg Oncol; 2017 Mar; 24(3):808-815. PubMed ID: 27770341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma.
    Chen Y; Yan H; Wang Y; Shi Y; Dai G
    Sci Rep; 2017 Apr; 7(1):753. PubMed ID: 28392554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma.
    Pointer DT; Roife D; Powers BD; Murimwa G; Elessawy S; Thompson ZJ; Schell MJ; Hodul PJ; Pimiento JM; Fleming JB; Malafa MP
    BMC Cancer; 2020 Aug; 20(1):750. PubMed ID: 32782024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma.
    Ben Q; An W; Wang L; Wang W; Yu L; Yuan Y
    Pancreas; 2015 Apr; 44(3):471-7. PubMed ID: 25423560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.
    Wang DS; Luo HY; Qiu MZ; Wang ZQ; Zhang DS; Wang FH; Li YH; Xu RH
    Med Oncol; 2012 Dec; 29(5):3092-100. PubMed ID: 22476808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between inflammation-based parameters and survival in metastatic pancreatic cancer.
    Turker S; Cilbir E; Guven DC; Karacin C; Yalcin S
    J Cancer Res Ther; 2021; 17(2):510-515. PubMed ID: 34121700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan.
    Inoue D; Ozaka M; Matsuyama M; Yamada I; Takano K; Saiura A; Ishii H
    Jpn J Clin Oncol; 2015 Jan; 45(1):61-6. PubMed ID: 25341546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT.
    Alagappan M; Pollom EL; von Eyben R; Kozak MM; Aggarwal S; Poultsides GA; Koong AC; Chang DT
    Am J Clin Oncol; 2018 Mar; 41(3):242-247. PubMed ID: 26757436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgical Resection.
    Kubo H; Murakami T; Matsuyama R; Yabushita Y; Tsuchiya N; Sawada Y; Homma Y; Kumamoto T; Endo I
    World J Surg; 2019 Dec; 43(12):3153-3160. PubMed ID: 31549202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma.
    Abe T; Amano H; Kobayashi T; Hanada K; Nakahara M; Ohdan H; Noriyuki T
    Eur J Surg Oncol; 2018 Oct; 44(10):1573-1579. PubMed ID: 29807728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer.
    Asaoka T; Miyamoto A; Maeda S; Tsujie M; Hama N; Yamamoto K; Miyake M; Haraguchi N; Nishikawa K; Hirao M; Ikeda M; Sekimoto M; Nakamori S
    Pancreatology; 2016; 16(3):434-40. PubMed ID: 26852169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer.
    Chawla A; Huang TL; Ibrahim AM; Hardacre JM; Siegel C; Ammori JB
    HPB (Oxford); 2018 May; 20(5):398-404. PubMed ID: 29221789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment blood neutrophil/lymphocyte ratio is associated with metastasis and predicts survival in patients with pancreatic cancer.
    Guo J; Wu M; Guo L; Zuo Q
    Bull Cancer; 2018 Feb; 105(2):146-154. PubMed ID: 29290332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy.
    Luo G; Guo M; Liu Z; Xiao Z; Jin K; Long J; Liu L; Liu C; Xu J; Ni Q; Yu X
    Ann Surg Oncol; 2015 Feb; 22(2):670-6. PubMed ID: 25155401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio.
    Bhatti I; Peacock O; Lloyd G; Larvin M; Hall RI
    Am J Surg; 2010 Aug; 200(2):197-203. PubMed ID: 20122680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.